Determination of plasma genistein fatty acid esters following administration of genistein or genistein 4′7-O-dioleate in monkeys

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1738, Issue 1-3, 2005, Pages 115-120

  Badeau, Maija ^a   Tikkanen, Matti J ^a   Appt, Susan E ^b   Adlercreutz, Herman ^a,d   Clarkson, Thomas B ^b   Hoikkala, Antti ^a   Wähälä, Kristiina ^a   Mikkola, Tomi S ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

Antioxidant; Atherosclerosis; Fatty acid; Genistein; Genistein 4 7 O dioleate; Time resolved fluoroimmunoassay

Indexed keywords

FATTY ACID ESTER; GENISTEIN; GENISTEIN 4'7 DIOLEATE; OLEIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FLUOROIMMUNOASSAY; HYDROLYSIS; MONKEY; NONHUMAN; PRIORITY JOURNAL; SAPONIFICATION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD CHEMICAL ANALYSIS; ESTERS; FATTY ACIDS; FEMALE; FLUOROIMMUNOASSAY; GENISTEIN; INJECTIONS, SUBCUTANEOUS; MACACA MULATTA; OLEIC ACIDS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; MACACA MULATTA;

EID: 31044434411     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2005.10.005     Document Type: Article

References (34)

1. G.M. Chisolm, and D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radical Biol. Med. 28 2000 1815 1826
2. M.B. Ruiz-Larrea, A.R. Mohan, G. Paganga, N.J. Miller, G.P. Bolwell, and C.A. Rice-Evans Antioxidant activity of phytoestrogenic isoflavones Free Radical Res. 26 1997 63 70
3. J.M. Hodgson, K.D. Croft, I.B. Puddey, T.A. Mori, and L.J. Beilin Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum J. Nutr. Biochem 7 1996 664 669
4. S. Kapiotis, M. Hermann, I. Held, C. Seelos, H. Ehringer, and B.M.K. Gmeiner Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL Arterioscler., Thromb., Vasc. Biol. 17 1997 2868 2874
5. M.J. Tikkanen, K. Wähälä, S. Ojala, V. Vihma, and H. Adlercreutz Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance Proc. Natl. Acad. Sci. U. S. A. 95 1998 3106 3110
6. M. Kaamanen, H. Adlercreutz, M. Jauhiainen, and M.J. Tikkanen Accumulation of genistein and lipophilic genistein derivatives in lipoproteins during incubation with human plasma in vitro Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1631 2003 147 152
7. G. Shwaery, J. Vita, and J.F. Keaney Jr. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol. Requirement for estradiol modification Circulation 95 1997 1378 1385
8. Q.-H. Meng, P. Lewis, K. Wähälä, H. Adlercreutz, and M.J. Tikkanen Incorporation of esterified soybean isoflavones with antioxidant activity into low density lipoprotein Biochim. Biophys. Acta 1438 1999 369 376
9. R.B. Hochberg Biological esterification of steroids Endocr. Rev. 19 1998 331 348
10. K.D.R. Setchell Absorption and metabolism of soy isoflavones-From food to dietary supplements and adults to infants J. Nutr. 130 2000 654S 655S
11. L. Wroblewski Lissin, and J.P. Cooke Phytoestrogens and cardiovascular health J. Am. Coll. Cardiol. 35 2000 1403 1410
12. G. Samsioe HRT and cardiovascular disease Ann. N. Y. Acad. Sci. 997 2003 358 372
13. K. Wähälä, and T.A. Hase Expedient synthesis of polyhydroxyisoflavones J. Chem. Soc., Perkin Trans. 1 1991 3005 3008
14. P.T. Lewis, K. Wähälä, A. Hoikkala, I. Mutikainen, Q.-H. Meng, H. Adlercreutz, and M.J. Tikkanen Synthesis of antioxidant isoflavone fatty acid esters Tetrahedron 56 2000 7805 7810
15. G.J. Wang, O. Lapcík, R. Hampl, M. Uehara, N. Al-Maharik, K. Stumpf, H. Mikola, K. Wähälä, and H. Adlercreutz Time-resolved fluoroimmunoassay of plasma daidzein and genistein Steroids 65 2000 339 348
16. V. Vihma, H. Adlercreutz, A. Tiitinen, P. Kiuru, K. Wähälä , and M.J. Tikkanen Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid Clin. Chem. 47 2001 1256 1262
17. S.R Shelnutt, C.O. Cimino, P.A. Wiggins, M.J.J. Ronis, and T.M. Badger Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage Am. J. Clin. Nutr. 76 2002 588 594
18. K.D.R. Setchell, and A. Cassidy Dietary isoflavones: biological effects and relevance to human health J. Nutr. 129 1999 758S 767S
19. 2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans Am. J. Clin. Nutr. 72 2000 395 400
20. T. Kanazawa, T. Osanai, X.S. Zhang, T. Uemura, X.Z. Yin, K. Onodera, Y. Oike, and K. Ohkubo Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases J. Nutr. 125 1995 639S 646S
21. S. Vega-López, K.-J. Yeum, J.L. Lecker, L.M. Ausman, E.J. Johnson, S. Devaraj, I. Jialal, and A.H. Lichtenstein Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones Am. J. Clin. Nutr. 81 2005 43 49
22. S. Samman, P.M. Lyons Wall, G.S.M. Chan, S.J. Smith, and P. Petocz The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women Atherosclerosis 147 1999 277 283
23. J.M. Hodgson, I.B. Puddey, K.D. Croft, T.A. Mori, J. Rivera, and L.J. Beilin Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure Atherosclerosis 145 1999 167 172
24. K.E. Heim, A.R. Tagliaferro, and D.J. Bobilya Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships J. Nutr. Biochem. 13 2002 572 584
25. C. Choi, H. Cho, J. Park, C. Cho, and Y. Song Suppressive effects of genistein on oxidative stress and NKκB activation in RAW 264.7 macrophages Biosci. Biotechnol. Biochem. 67 2003 1916 1922
26. P.N. Paradkar, P.S. Blum, M.A. Berhow, H. Baumann, and S.-M. Kuo Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine Cancer Lett. 215 2004 21 28
27. FDA Food labeling health claims: soybean protein and coronary heart disease. Food and Drug Administration. Final rule Fed. Regist. 64 1999 57699 57733
28. M.J.J. de Klejin, Y.T. van der Schouw, P.W.F. Wilson, D.E. Grobbee, and P.F. Jacques Dietary intake of phytoestrogens is associated with favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham Study J. Nutr. 132 2002 276 282
29. S. Castiglioni, C. Manzoni, A. D'Uva, R. Spiezie, E. Monteggia, G. Chiesa, C.R. Sirtori, and M.R. Lovati Soy proteins reduce progression of a focal lesion and lipoprotein oxidiability in rabbits fed a cholesterol-rich diet Atherosclerosis 171 2003 163 170
30. T.B. Clarkson Soy, soy phytoestrogens and cardiovascular disease J. Nutr. 132 2002 566S 569S
31. E.K. Honore, J.K. Williams, M.S. Anthony, and T.B. Clarkson Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques Fertil. Steril. 67 1997 148 154
32. H. Helisten, A. Höckerstedt, K. Wähälä, A. Tiitinen, H. Adlercreutz, M. Jauhiainen, and M.J. Tikkanen Accumulation of high-density lipoprotein-derived estradiol-17β fatty acid esters in low-density lipoprotein particles J. Clin. Endocrinol. Metab. 86 2001 1294 1300
33. 3 subfraction J. Lipid Res. 43 2002 392 397
34. M.J. Tikkanen, V. Vihma, M. Jauhiainen, A. Höckerstedt, H. Helisten, and M. Kaamanen Lipoprotein-associated estrogens Cardiovasc. Res. 56 2002 184 188